Epidemiological Survey of Human Alphaherpesvirus 2 (HSV-2) Infection in Indigenous People of Dourados Municipality, Central Brazil.

ethnicity human alphaherpesvirus 2 human herpes virus 2 indigenous

Journal

Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042

Informations de publication

Date de publication:
29 Mar 2023
Historique:
received: 27 10 2022
revised: 10 01 2023
accepted: 23 01 2023
medline: 27 4 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: epublish

Résumé

Sexually transmitted Human alphaherpesvirus 2 (HSV-2) causes genital ulcers, especially among sexually active adolescents and adults. We estimated the exact prevalence of anti-HSV-2 antibodies and correlated it with the demographic and behavioral aspects of the Indigenous population of the Jaguapirú and Bororó villages (Dourados, Mato Grosso do Sul (MS), Brazil). In total, 1360 individuals (>18 years old) were administered serologic tests. The prevalence of anti-HSV-2 IgM was 12.9%, that of anti-HSV-2 IgG was 57.2%, and 8.5% cases tested positive for both HSV-2 IgM and IgG. The prevalence of anti-HSV-2 antibodies was higher in females (59.5%) compared to males (49%), with an OR of 0.64 (0.49-0.83). Anti-HSV-2 antibodies were found in 14.2%, 12.3%, 15.4%, and 14.5% of participants with urinary problems, genital wounds, genital warts, and urethral discharge, respectively. In summary, the seroprevalence of HSV-2 in the Indigenous population was five times higher than that reported in the general adult Brazilian population. Educational level, income level, smoking, condom use, incarceration, illicit drug abuse, the sharing of used needles and syringes without adequate disinfection, homosexual relationships, prostitution, the sexual practices among drug users, and avoidance of contraceptive methods could contribute to the facilitation of HSV-2 transmission in the Indigenous population. Our results may help develop culturally appropriate intervention programs that eliminate health-access barriers and improve the implementation of public health policies aimed at promoting information regarding and preventing, treating, and controlling HSV-2 infection in Brazilian Indigenous populations.

Identifiants

pubmed: 37104324
pii: tropicalmed8040197
doi: 10.3390/tropicalmed8040197
pmc: PMC10143357
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Rev Saude Publica. 2010 Aug;44(4):726-34
pubmed: 20676563
N Engl J Med. 1997 Aug 21;337(8):509-15
pubmed: 9262493
JAMA. 1992 Apr 15;267(15):2062-6
pubmed: 1485894
J Virol. 2019 May 15;93(11):
pubmed: 30894469
J Immunol. 1964 Apr;92:602-10
pubmed: 14139032
Coll Antropol. 2006 Dec;30 Suppl 2:63-70
pubmed: 17508477
J Eur Acad Dermatol Venereol. 2006 Mar;20(3):347-9
pubmed: 16503907
Bull World Health Organ. 2020 May 01;98(5):315-329
pubmed: 32514197
J Infect Dev Ctries. 2010 Oct 04;4(9):572-5
pubmed: 21045370
Sex Health. 2010 Dec;7(4):453-9
pubmed: 21062586
Am J Public Health. 1991 Feb;81(2):194-6
pubmed: 1990857
Coll Antropol. 2011 Mar;35(1):9-14
pubmed: 21661348
Lancet. 2007 Dec 22;370(9605):2127-37
pubmed: 18156035
Rev Saude Publica. 2019 Sep 09;53:71
pubmed: 31508778
J Med Virol. 2002 Jul;67(3):345-8
pubmed: 12116025
J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45
pubmed: 15021308
AIDS Behav. 2021 Nov;25(11):3669-3686
pubmed: 33772695
J Infect Dis. 2006 Apr 1;193(7):905-11
pubmed: 16518750
Indian J Med Res. 2010 Apr;131:559-64
pubmed: 20424308
Rev Salud Publica (Bogota). 2018 May-Jun;20(3):293-300
pubmed: 30844000
Clin Infect Dis. 2016 Feb 15;62(4):456-61
pubmed: 26578538
Arch Virol. 2009;154(1):171-7
pubmed: 19066710
Infect Dis Poverty. 2020 Jan 28;9(1):10
pubmed: 31987053
Sex Transm Infect. 2006 Apr;82(2):164-8
pubmed: 16581748
BMC Infect Dis. 2019 May 22;19(1):459
pubmed: 31117977
N Engl J Med. 1999 Nov 4;341(19):1432-8
pubmed: 10547406
J Clin Diagn Res. 2014 Dec;8(12):DC16-9
pubmed: 25653947
Pol Merkur Lekarski. 2005 Nov;19(113):719-22
pubmed: 16498820
Geburtshilfe Frauenheilkd. 2016 Dec;76(12):1310-1317
pubmed: 28017972
Clin Infect Dis. 1994 Jul;19(1):33-41
pubmed: 7948555
BMC Public Health. 2006 Feb 27;6:49
pubmed: 16504147
Clin Infect Dis. 2004 Nov 15;39(10):1433-8
pubmed: 15546077
Hum Biol. 2002 Oct;74(5):633-44
pubmed: 12495078
Virol J. 2009 Apr 06;6:40
pubmed: 19348670
Br J Nurs. 2016 Jun 23;25(12):676-80
pubmed: 27345071
PLoS One. 2013 May 21;8(5):e63953
pubmed: 23704961
J Infect Dis. 2002 Oct 15;186 Suppl 1:S3-28
pubmed: 12353183
AIDS. 2006 Jan 9;20(2):261-7
pubmed: 16511420
Eur Respir J. 2010 Jan;35(1):27-33
pubmed: 20044459
JAMA. 2006 Aug 23;296(8):964-73
pubmed: 16926356
Int J Infect Dis. 2010 Sep;14 Suppl 3:e25-31
pubmed: 20106695
Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28(7):1098-110
pubmed: 25153069
Int J Infect Dis. 1998-1999 Winter;3(2):94-8
pubmed: 10225987
J Neurol. 2010 Sep;257(9):1432-7
pubmed: 20495814
BMJ Clin Evid. 2011 Apr 15;2011:
pubmed: 21496359
J Infect Dis. 1999 Jan;179(1):16-24
pubmed: 9841817
J Med Virol. 2007 Feb;79(2):167-73
pubmed: 17177300
Nat Med. 2009 Aug;15(8):886-92
pubmed: 19648930
Sex Transm Dis. 2006 Jul;33(7):416-21
pubmed: 16601657
Sex Transm Infect. 2021 Aug;97(5):351-356
pubmed: 33106440
AIDS. 2006 Jan 2;20(1):73-83
pubmed: 16327322
In Vivo. 1999 Nov-Dec;13(6):463-6
pubmed: 10757038
Ann Intern Med. 1973 Aug;79(2):225-8
pubmed: 4125441
Am J Trop Med Hyg. 2019 Jul;101(1):45-50
pubmed: 31162016
PLoS One. 2015 May 20;10(5):e0128615
pubmed: 25992922
Sex Transm Dis. 2019 Dec;46(12):780-787
pubmed: 31596737

Auteurs

Flávia Freitas de Oliveira Bonfim (FFO)

Virology Molecular Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro 21040360, Brazil.

Livia Melo Villar (LM)

Viral Hepatitis Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro 21040360, Brazil.

Julio Croda (J)

Brazilian Society of Tropical Medicine, Campo Grande 79070900, Brazil.

Solange Rodrigues da Silva (SRD)

Binacional Campus of Oiapoque, Federal University of Amapá, Macapá 68903419, Brazil.

Crhistinne Cavalheiro Maymone Gonçalves (CCM)

Center for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande 79070900, Brazil.
State Department of Health of Mato Grosso do Sul, Campo Grande 79031350, Brazil.

Vivianne de Oliveira Landgraf de Castro (VOL)

Environmental Analysis Laboratory, Southern Cross University, Military Road East, Lismore, NSW 2480, Australia.

Grazielli Rocha de Rezende Romeira (GR)

Center for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande 79070900, Brazil.

Gabriela Alves Cesar (GA)

Center for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande 79070900, Brazil.

Sabrina Moreira Dos Santos Weis-Torres (SM)

Center for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande 79070900, Brazil.

Marco Aurélio Horta (MA)

Biosafety Level 3 Platform (NB3), Oswaldo Cruz Foundation, Rio de Janeiro 21040360, Brazil.

Simone Simionatto (S)

College of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79070900, Brazil.

Ana Rita Coimbra Motta-Castro (ARC)

Center for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande 79070900, Brazil.
Center for Health and Biological Sciences, Oswaldo Cruz Foundation, Rio de Janeiro 79070900, Brazil.

Vanessa Salete de Paula (VS)

Virology Molecular Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro 21040360, Brazil.

Classifications MeSH